NOX 3.08% 6.7¢ noxopharm limited

Agree that P&L is important but probably not critical at this...

  1. 2,282 Posts.
    lightbulb Created with Sketch. 626
    Agree that P&L is important but probably not critical at this stage as long as cash fund or funding resources are not an issue especially intos are cash rich and hungry for new life science to save/extend life and/or survival !

    At this stage, prefer not to count the pennies and lose the pounds...as long as research is heading the right direction >>>>COMMERCIALISATION.

    Hopefully the new USA set up Pharmorage Ltd focussing on development around the business of sepsis and autoimmunity will also bear fruits soon !

    Happy to “risk” my pennies in the hands of Dr Kelly who seems to be an ALL ROUNDER CEO as most biotec CEOs are usually good at science but lacking in marketing communication, or vice versa.

    He has a Midas Touch too !


    Dyor GLAH


 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.002(3.08%)
Mkt cap ! $19.58M
Open High Low Value Volume
6.5¢ 6.7¢ 6.5¢ $2.465K 37.67K

Buyers (Bids)

No. Vol. Price($)
2 32000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 88899 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
6.5¢
  Change
0.002 ( 2.36 %)
Open High Low Volume
6.5¢ 6.5¢ 6.2¢ 21992
Last updated 15.32pm 28/03/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.